BioNxt Solutions Inc. (CVE:BNXT) | WebDisclosure

Basculer en Français

10626	Companies
225839	Keywords
154362	Articles
119502	Press releases

Headlines Articles Press releases BioNxt Solutions Inc.

Home
Companies
BioNxt Solutions Inc.

PRESS RELEASE

published on 10/02/2025 at 09:05, 8 months 22 days ago

BioNxt Reports Update on Targeted Chemotherapy Drug Delivery Platform
BioNxt Solutions Inc. reports significant advancement in targeted chemotherapy delivery platform and upcoming definitive agreement. Proprietary technology aims at 10-fold increase in therapeutic effect while safeguarding healthy cells

BioNxt Solutions Inc. Oncology Treatments Chemotherapy Delivery Platform Targeted Drug Delivery System Therapeutic Effect
BRIEF

published on 09/29/2025 at 09:10, 8 months 25 days ago

BioNxt Advances Cladribine Sublingual Drug Development for Multiple Sclerosis

Drug Development Multiple Sclerosis Cladribine Bioavailability Sublingual
BRIEF

published on 09/29/2025 at 09:10, 8 months 25 days ago

BioNxt fait progresser le développement d'un médicament sublingual à base de cladribine pour le traitement de la sclérose en plaques

Sclérose En Plaques Cladribine Développement De Médicaments Biodisponibilité Sublingual
PRESS RELEASE

published on 09/29/2025 at 09:05, 8 months 25 days ago

BioNxt Reports Sublingual Cladribine Multiple Sclerosis Drug Milestones Including Large-Animal Study for Validation and Dosing Optimization
BioNxt Solutions provides update on Cladribine sublingual thin-film drug reformulation program, targeting treatment of multiple sclerosis with improved bioavailability and patient adherence

Multiple Sclerosis Cladribine Neurological Disorders BioNxt Solutions Drug Delivery Technologies
BRIEF

published on 09/20/2025 at 03:50, 9 months 4 days ago

BioNxt Solutions Completes Shares for Debt Settlement

Common Shares Debt Settlement Debt Agreement Canadian Securities BioNxt Solutions
BRIEF

published on 09/20/2025 at 03:50, 9 months 4 days ago

BioNxt Solutions lève des actions pour régler sa dette

Actions Ordinaires Règlement De La Dette Solutions BioNxt Valeurs Mobilières Canadiennes Accord De Dette
PRESS RELEASE

published on 09/20/2025 at 03:45, 9 months 4 days ago

BioNxt Solutions Announces Closing of Shares for Debt Settlement
BioNxt Solutions Inc. announces successful debt settlement with creditor, issuing common shares and making cash payment. Company focuses on bioscience innovation and drug delivery technologies

Common Shares Debt Settlement BioNxt Solutions Inc. Drug Delivery Technologies Bioscience Innovation
BRIEF

published on 09/20/2025 at 01:35, 9 months 4 days ago

BioNxt Solutions Inc. Engages Capital Markets Advisor and Investor Relations Professionals

Stock Options Investor Relations Capital Markets BioNxt Solutions Terry Lynch
BRIEF

published on 09/20/2025 at 01:35, 9 months 4 days ago

BioNxt Solutions Inc. fait appel à des conseillers en marchés financiers et à des professionnels des relations avec les investisseurs.

Relations Avec Les Investisseurs Marchés Des Capitaux Options Sur Actions Solutions BioNxt Terry Lynch
PRESS RELEASE

published on 09/20/2025 at 01:30, 9 months 4 days ago

Terry Lynch Continues as Capital Markets Advisor and BioNxt Retains Investor Relations Professionals
BioNxt Solutions Inc. announces Terry Lynch as capital markets advisor and retention of two investor relations professionals, Rob Grace and Blaine Ruzcki, for promotional activities. Company focuses on bioscience innovations with drug delivery platforms

BioNxt Solutions Inc. Terry Lynch Investor Relations Professionals Bioscience Innovations Drug Delivery Platforms

Accesswire

Published on 06/24/2026 at 10:12, 2 hours 6 minutes ago

Silver Range Expands Alamo Gold-Copper Target
Published on 06/24/2026 at 03:15, 9 hours 3 minutes ago

Noram Lithium Adopts Semi-Annual Financial Reporting
Published on 06/24/2026 at 00:00, 12 hours 18 minutes ago

Onco-Innovations Engages Nanosoft Polymers to Advance Polymer and Drug Delivery Development for ONC010
Published on 06/23/2026 at 23:45, 12 hours 33 minutes ago

Prospect Ridge Aligns with the Market Mindset for Exclusive Live Investor Interview Discussing Game-changing 2026 Drill Programs
Published on 06/23/2026 at 23:20, 12 hours 58 minutes ago

BioNxt Announces Closing of Non-brokered Private Placement of Units Pursuant to the Listed Issuer Exemption

View all ACCESSWIRE

EQS Group

Published on 06/24/2026 at 12:05, 13 minutes ago

H.I.G. Capital Appoints Carlos Couret as Managing Director and Head of Lower Middle Market Private Equity in Spain
Published on 06/24/2026 at 12:00, 18 minutes ago

HKSTP Forges An Asia–Europe Innovation Gateway at VivaTech 2026
Published on 06/24/2026 at 11:45, 32 minutes ago

Tender Offer Results Announcement
Published on 06/24/2026 at 11:30, 48 minutes ago

Ottobock appoints Dr. Katarzyna Mazur-Hofsaess to the Management Board
Published on 06/24/2026 at 11:00, 1 hour 18 minutes ago

Chauffage à distance de Payerne : pose de la première pierre de la centrale thermique.

Les Echos

Published on 06/24/2026 at 09:30, 2 hours 48 minutes ago

CP HOPENING - Le 1er Baromètre “Libéralités - Grande Transmission”
Published on 06/23/2026 at 19:47, 16 hours 30 minutes ago

GROUPE SFPI: reorganisation de la Direction Générale
Published on 06/23/2026 at 19:47, 16 hours 30 minutes ago

GROUPE SFPI: General management reorganisation
Published on 06/23/2026 at 19:10, 17 hours 8 minutes ago

GUILLEMOT CORPORATION > EVOLUTION DE LA GOUVERNANCE A COMPTER DU 23 JUIN 2026
Published on 06/23/2026 at 19:10, 17 hours 8 minutes ago

GUILLEMOT CORPORATION: Changes to Corporate Governance Effective June 23, 2026

View all LES ECHOS COMFI WIRE